ASCO: Melanoma Rates on the Rise for U.S. Youth

This article originally appeared here.
Share this content:
ASCO: Melanoma Rates on the Rise for U.S. Youth
ASCO: Melanoma Rates on the Rise for U.S. Youth

WEDNESDAY, June 3, 2015 (HealthDay News) -- Melanoma incidence has increased by 253 percent among U.S. children and young adults since the 1970s, and young women appear to be especially vulnerable, accounting for two-thirds of cases diagnosed in 2011. These findings are scheduled for presentation this week at the annual meeting of the American Society of Clinical Oncology, held from May 29 to June 2 in Chicago.

For the study, investigators analyzed 35,726 cases of melanoma among patients younger than age 40 and diagnosed between 1973 and 2011. Ninety-eight percent of the cases involved teens and young adults between 15 and 39.

While women accounted for 57 percent of melanomas reported between 1973 and 1980, they comprised about 65 percent of all diagnoses by 2011. The researchers said this is likely because of unsafe tanning practices. While 4 percent of melanoma cases diagnosed before 1980 were classified as noninvasive and early stage, these cancers accounted for more than 20 percent of all cases by 2011. Melanoma survival rates are also on the rise, increasing from 80 percent in the mid-to-late 1970s to 95 percent in 2011.

"Given the epidemic rise of melanoma cases diagnosed among children, adolescents, and young adults, it is imperative that new research initiatives are implemented, genetic and environmental risk factors identified, and effective prevention and screening strategies employed," lead author Demytra Krista Lee Mitsis, M.D., of the Roswell Park Cancer Institute in Buffalo, N.Y., said in an institute news release.

Two authors disclosed financial ties to the pharmaceutical industry.

Abstract
More Information

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

Plan to Relax Coal-Fired Power Plant Rules Could Up Mortality

Plan to Relax Coal-Fired Power Plant Rules Could ...

EPA predicts between 470 and 1,400 premature deaths a year by 2030

FDA Extends EpiPen Expiration Dates to Tackle Shortage

FDA Extends EpiPen Expiration Dates to Tackle Shortage

Shortages due to factors such as supply disruptions and manufacturer issues

USPSTF Updates Guidance for Cervical Cancer Screening

USPSTF Updates Guidance for Cervical Cancer Screening

Cytology recommended every three years from age 21; different screening options from age 30 to 65

is free, fast, and customized just for you!




Already a member?

Sign In Now »